Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

2023; Elsevier BV; Volume: 34; Issue: 10 Linguagem: Inglês

10.1016/j.annonc.2023.08.004

ISSN

1569-8041

Autores

Heather A. Parsons, Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong, Vandana G. Abramson, Ayan R. Patel, Justin Cheng, Adam Brufsky, Justin Rhoades, Jeremy Force, Rong Liu, Tiffany A. Traina, Lisa A. Carey, Mothaffar F. Rimawi, Kathy D. Miller, Vered Stearns, Jennifer M. Specht, Carla I. Falkson, Harold J. Burstein, Antonio C. Wolff, Eric P. Winer, Nabihah Tayob, Ian E. Krop, G. Mike Makrigiorgos, Todd R. Golub, Erica L. Mayer, Viktor A. Adalsteinsson,

Tópico(s)

Genetic factors in colorectal cancer

Resumo

We aimed to examine circulating tumor DNA (ctDNA) and its association with residual cancer burden (RCB) using an ultrasensitive assay in patients with triple-negative breast cancer (TNBC) receiving neoadjuvant chemotherapy.

Referência(s)